Familial amyloid neuropathy

From WikiMD's WELLNESSPEDIA


Familial amyloid neuropathy
Synonyms Transthyretin amyloidosis, ATTR amyloidosis
Pronounce N/A
Specialty N/A
Symptoms Peripheral neuropathy, autonomic dysfunction, cardiomyopathy, nephropathy
Complications N/A
Onset Typically between ages 20 and 40
Duration Progressive
Types N/A
Causes Mutations in the TTR gene
Risks Family history
Diagnosis Genetic testing, biopsy, imaging studies
Differential diagnosis Chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy
Prevention N/A
Treatment Liver transplantation, tafamidis, diflunisal, patisiran, inotersen
Medication N/A
Prognosis Variable, depends on mutation and treatment
Frequency Rare
Deaths N/A


Familial amyloid neuropathy (FAN), also known as Familial amyloid polyneuropathy (FAP), is a rare genetic disorder characterized by the production of abnormal protein deposits, known as amyloid, in various tissues and organs of the body. These deposits can lead to a wide range of symptoms, depending on the organs affected.

Etiology[edit]

FAN is caused by mutations in the Transthyretin (TTR) gene. This gene provides instructions for making a protein that carries thyroid hormones in the blood and cerebrospinal fluid. Mutations in the TTR gene cause the protein to misfold, leading to the formation of amyloid deposits.

Symptoms[edit]

The symptoms of FAN can vary widely, depending on the organs affected by the amyloid deposits. Common symptoms include peripheral neuropathy, autonomic neuropathy, and cardiomyopathy. Other symptoms can include gastrointestinal disturbances, renal dysfunction, and ophthalmological problems.

Diagnosis[edit]

Diagnosis of FAN is based on a combination of clinical symptoms, family history, and genetic testing. Biopsies of affected tissues can also be used to confirm the presence of amyloid deposits.

Treatment[edit]

Treatment for FAN is aimed at managing symptoms and slowing the progression of the disease. This can include medications to manage neuropathic pain and gastrointestinal symptoms, as well as interventions to manage cardiac and renal complications. In some cases, liver transplantation or stem cell transplantation may be considered.

Prognosis[edit]

The prognosis for individuals with FAN can vary widely, depending on the specific mutation in the TTR gene, the organs affected, and the individual's overall health. With appropriate management, many individuals with FAN can lead productive lives.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.